Citius Oncology, Inc. (CTOR)

NASDAQ

$0.70

$-0.01

(-1.43%)

Regular Market

Citius Oncology, Inc. (CTOR) Live Price Chart

Last updated: ⁦2026-10-21 18:02:00⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Citius Oncology, Inc. (CTOR) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.70, with a market capitalization of $75.13M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.49 to $1.93. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$75.13M
Open	$0.71
Day's High	$6.19
Day's Low	$0.49
Previous Close	$0.67
Volume	13.75K
Average Volume	98.75K
P/E Ratio	--
52-Week High	$1.93
52-Week Low	$0.49
Dividend Yield	--
Earnings Date	--

Citius Oncology, Inc. (CTOR) Stock Price Today

Citius Oncology, Inc. (CTOR) is currently trading at $0.70 as of 2026-10-21 17:58:00, up 3.58% ($0.02) from the previous close of $0.67

During today's regular trading session, CTOR has traded between $0.49 and $6.19, with a trading volume of 13.75K shares. The current price is near the lower end of today's range.

Citius Oncology, Inc. (CTOR) 7-Day Stock Price Change

Over the past seven days, Citius Oncology, Inc. (CTOR) moved from $0.81 to $0.70, representing a decline of 14.47% ($0.12).

The stock traded between $0.66 and $0.86 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 50.38 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

CTOR 52-Week Price Position

Position in Range: 14.2%

52W Low$0.49

52W High$1.93

CTOR is currently trading at $0.70, placing it 14.2% of the way from its 52-week low of $0.49 to its 52-week high of $1.93. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Citius Oncology, Inc. (CTOR)?

Citius Oncology Inc is a biopharmaceutical company focused on developing and commercializing targeted oncology therapies.The Company centers on achieving a market position by advancing therapies with reduced development and clinical risks, and competitive advantages supported by intellectual property and regulatory exclusivity protection. This includes new formulations of previously approved drugs with substantial existing safety and efficacy data or expanded indications for approved therapies. The company focused on key geographies and stakeholders, majorly on cancer centers and patients.

Citius Oncology, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Exchange	NASDAQ
Company Website	https://www.citiusonc.com

How to Buy Citius Oncology, Inc. (CTOR) Stock on MEXC

Eligible investors can buy real shares of Citius Oncology, Inc. (CTOR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CTOR and Place Your Order

Open the RealStocks trading page and search for CTOR. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Citius Oncology, Inc. (CTOR) stock price today?

Citius Oncology, Inc. (CTOR) is currently trading at $ 0.70, up 3.58% ($0.02) from the previous close of $ 0.67. Intraday prices update in real time during regular trading hours.

2.Is CTOR stock going up or down today?

As of 2026-10-21 17:58:00, CTOR is trading at $ 0.70, up 3.58% ($0.02) from its previous close of $ 0.67. The stock has traded between $ 0.49 and $ 6.19 during today’s regular session. Past price movements do not guarantee future results.

3.What is CTOR pre-market price?

As of 2026-10-21 17:58:00, CTOR is trading at $ 0.67 in pre-market trading, up 0.45% ($0.00) from the previous close of $ 0.67. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CTOR after-hours price?

As of 2026-10-21 17:58:00, CTOR is trading at $ 0.67 in after-hours trading, up 0.45% ($0.00) from the regular-session close of $ 0.67. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CTOR stock trading now?

CTOR trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CTOR sit relative to its 52-week high and low?

Over the past 52 weeks, CTOR has traded between a low of $ 0.49 and a high of $ 1.93. At $ 0.70, the stock is positioned 14.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Citius Oncology, Inc. in?

Citius Oncology, Inc. (CTOR) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Citius Oncology, Inc.'s market capitalization and where is it listed?

Citius Oncology, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 75.13M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CTOR valued in terms of P/E ratio and EPS?

CTOR trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.44. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Citius Oncology, Inc. pay a dividend?

Citius Oncology, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.